The Janus kinase inhibitor baricitinib, in combination with narrowband ultraviolet B therapy, improved vitiligo, according to ...

Discover a study that explores the effectiveness of JAK inhibitors to treat dermatological autoimmunity for people with Down ...

One study documented the use of tofacitinib, a Janus kinase (JAK) inhibitor, in two patients with Morbihan disease. Both patients showed significant improvement in their symptoms after a short ...

1 Zenrelia, which received FDA approval in September 2024, is a once-daily Janus kinase (JAK) inhibitor used for controlling pruritus associated with allergic dermatitis and atopic dermatitis for ...

Therefore, to bridge the gap of unmet need, the pharmaceutical industry is working towards biologics and targeted therapies such as monoclonal antibodies, Janus kinase (JAK) inhibitors, and ...